Simplify the future of transplant testing
Reimagine your transplant workflow to achieve same day turnaround by consolidating your complete test menu on a single high-throughput platform.
Hologic's Molecular Scalable Solutions now includes a fully automated CMV testing solution, combining a high-performing assay portfolio with advanced automation.
Simplify, standardise and accelerate transplant testing on the Panther® system
By integrating your transplant, viral load, respiratory, STI and women's health testing on a single, fully automated high-throughput system you can deliver greater accuracy, traceability and operational efficiency.
Diagnostic precision and flexibility across transplant matrices
The Aptima® CMV Quant assay is the first in a series of quantitative assays to support patient management following transplant surgery.
Specificity: Plasma - 99.7% (389/390) Whole Blood - 100% (390/390)1
Analytical sensitivity: Plasma - 53 IU/mL Whole blood - 131 IU/mL1
Drug resistant CMV specimens detection1
Direct loading of plasma primary tube
Standardised to the first WHO International Standard for human cytomegalovirus, improving cross lab and country quantification and comparison
Confidence and control across a complete menu
The Panther Fusion® EBV Quant and Panther Fusion BKV Quant assays, developed and manufactured in Europe, are now CE marked.
These high-performance on-demand assays work on the automated Panther Fusion® system within a same day turnaround to facilitate active patient monitoring and treatment planning. By removing the need to schedule batch testing, workflow optimisation becomes more streamlined.
Our commitment to innovation doesn't stop there. Our team of scientists is hard at work developing additional assays to strengthen your testing capabilities. More to come on this.
Please provide your details below to find out more about consolidating and simplifying the future of your transplant testing
